Biodesix
BDSX
NASDAQ
IPO2020
about BDSX
Biodesix provides clinical diagnostic solutions focused on precision medicine, utilizing its proprietary liquid biopsy technology to detect diseases early, monitor treatment responses, and assess therapeutic risks for patients and clinicians.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.00 | $9.83 | $6.94 | $43.44M | 62.68M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.16 | n/a | 2.90 | -32.39% | -40.04% | 0% |